US Patent 7276515 Thioether substituted imidazoquinolines
Patent 7276515 was granted and assigned to Coley Pharmaceutical Group on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Joseph F. Dellaria0
Matthew R. Radmer0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+374 characters)
Article
Patent abstract
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07276515 Thioether substituted imidazoquinolines US Patent 7276515 Thioether substituted imidazoquinolines
Infobox
Patent Number
07276515
Patent Number
7276515
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07276515 Thioether substituted imidazoquinolines
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07276515
Date of patent
October 2, 2007
Patent application number
11133425
Date Filed
May 19, 2005
Patent primary examiner
Find more entities like US Patent 7276515 Thioether substituted imidazoquinolines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.